A novel pathway for amyloid precursor protein processing

详细信息    查看全文

• 作者：Erik Portelius^a ; ^{erik.portelius@neuro.gu.se"" rel=""nofollow} ; Eric Price^b ; Gunnar Brinkmalm^a ; Mark Stiteler^b ; Maria Olsson^a ; Rita Persson^a ; Ann Westman-Brinkmalm^a ; Henrik Zetterberg^a ; Adam J. Simon^b ; Kaj Blennow^a
• 关键词：Alzheimer's disease ; Immunoprecipitation ; Mass spectrometry ; Aβ ; APP ; α ; -Secretase ; β ; -Secretase
• 刊名：Neurobiology of Aging
• 出版年：2011
• 出版时间：June 2011
• 年：2011
• 卷：32
• 期：6
• 页码：1090-1098
• 全文大小：1204 K

文摘

Amyloid precursor protein (APP) can be proteolytically processed along two pathways, the amyloidogenic that leads to the formation of the 40–42 amino acid long Alzheimer-associated amyloid β (Aβ) peptide and the non-amyloidogenic in which APP is cut in the middle of the Aβ domain thus precluding Aβ formation. Using immunoprecipitation and mass spectrometry we have shown that Aβ is present in cerebrospinal fluid (CSF) as several shorter isoforms in addition to Aβ1–40 and Aβ1–42. To address the question by which processing pathways these shorter isoforms arise, we have developed a cell model that accurately reflects the Aβ isoform pattern in CSF. Using this model, we determined changes in the Aβ isoform pattern induced by α-, β-, and γ-secretase inhibitor treatment. All isoforms longer than and including Aβ1–17 were γ-secretase dependent whereas shorter isoforms were γ-secretase independent. These shorter isoforms, including Aβ1–14 and Aβ1–15, were reduced by treatment with α- and β-secretase inhibitors, which suggests the existence of a third and previously unknown APP processing pathway involving concerted cleavages of APP by α- and β-secretase.